CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $654 | -16.0% | 23,780 | +3.6% | 0.00% | 0.0% |
| Q2 2023 | $779 | -21.4% | 22,959 | -16.6% | 0.00% | 0.0% |
| Q1 2023 | $991 | -32.0% | 27,545 | -15.7% | 0.00% | -50.0% |
| Q4 2022 | $1,457 | -99.8% | 32,679 | -0.1% | 0.00% | +100.0% |
| Q3 2022 | $920,000 | +4.7% | 32,719 | +0.3% | 0.00% | 0.0% |
| Q2 2022 | $879,000 | -21.1% | 32,622 | -0.3% | 0.00% | 0.0% |
| Q1 2022 | $1,114,000 | -11.8% | 32,705 | +0.1% | 0.00% | 0.0% |
| Q4 2021 | $1,263,000 | -23.4% | 32,681 | +7.1% | 0.00% | -50.0% |
| Q3 2021 | $1,648,000 | +46.6% | 30,516 | -9.2% | 0.00% | +100.0% |
| Q2 2021 | $1,124,000 | – | 33,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,605,390 | $71,552,232 | 10.98% |
| Octagon Capital Advisors LP | 761,398 | $33,935,509 | 5.28% |
| TSP Capital Management Group, LLC | 269,895 | $12,029,225 | 4.50% |
| Redmile Group, LLC | 1,977,451 | $88,134,991 | 3.60% |
| COMMODORE CAPITAL LP | 495,823 | $22,099 | 3.33% |
| Tri Locum Partners LP | 176,109 | $7,849,000 | 3.18% |
| ACUTA CAPITAL PARTNERS, LLC | 115,000 | $5,125,550 | 3.15% |
| Ikarian Capital, LLC | 267,476 | $11,921,406 | 2.88% |
| RTW INVESTMENTS, LP | 3,084,215 | $137,463,463 | 2.81% |
| Eversept Partners, LP | 558,774 | $24,904,557 | 2.18% |